Home
About
Overview
Sharing Data
ORCID
Help
History (5)
A Gynecologic Oncology Group phase II trial of the protein kinase C-beta inhibitor, enzastaurin and evaluation of markers with potential predictive and prognostic value in persistent or recurrent epithelial ovarian and primary peritoneal malignancies.
Bicuspid
Germ Layers
Paraneoplastic Syndromes, Ocular
Smiling, Bradley
See All 5 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Bradley Mark Smiling
Title
Resident
Institution
University of Oklahoma Health Sciences Center
Department
Fam Practice OKC Residency Pgm
Address
FMC 2604
900 NE 10th St
Oklahoma City OK 73104
vCard
Download vCard
Same Department
People who are also in this person's primary department.
Frazier, Brett
Holbrook, Erik
Klump, Kathryn
Ramakrishnan, Kalyanakrishnan
Salinas, Roberto
Explore
_